AWAdrian Raymond Walker

Adrian Raymond Walker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adrian Raymond Walker has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perinatal mental health outcomes for people with intellectual disability: A data linkage study in New South Wales, Australia

    by Rachael C. Cvejic, Tim R. Watkins, Adrian R. Walker, Janelle Weise, Bronwyn K. Brew, Nicole Reilly, Simone Reppermund, Rebecca Koncz, Preeyaporn Srasuebkul, Julian N. Trollor

    Objective: To describe perinatal mental health outcomes among people with intellectual disability giving birth in New South Wales, Australia. Methods: This retrospective, descriptive cohort study included 30,257 people (2262 people with intellectual disability and 27,995 comparators without intellectual disability) aged 10+ years, discharged from New South Wales hospitals between 2002 and 2017 following a live singleton birth. We used administrative data from emergency departments, hospitals, ambulatory mental health services, Medicare-subsidised services and the Pharmaceutical Benefits Scheme. We defined the overall perinatal period as 140 days before to 365 days after birth. We also examined outcomes within four specific timeframes: 140 days to birth, 1–42, 43–90 and 91–365 days after birth. Results: Across the overall perinatal period, people with intellectual disability who gave birth had greater risk of having at least one mental health emergency department presentation (risk ratio = 7.01 (5.78–8.50)), mental health hospital admission (risk ratio = 8.97 (7.54–10.67)), ambulatory mental health service contact (risk ratio = 5.55 (4.90–6.28)) and Medicare-subsidised mental health service contact (risk ratio = 1.99 (1.82–2.16)) than comparators. The most common diagnoses among people with intellectual disability were mood (12.6%; risk ratio = 3.83 (3.38–4.35)) and anxiety, stress-related and somatoform disorders (11.9%; risk ratio = 3.62 (3.19–4.12)). People with intellectual disability were more likely to be dispensed antipsychotics (risk ratio = 9.29 (7.74–11.16)), anxiolytics (risk ratio = 3.03 (2.44–3.76)), hypnotics/sedatives (risk ratio = 2.08 (1.55–2.78)), antidepressants (risk ratio = 2.30 (2.13–2.49)) and psychostimulants (risk ratio = 4.00 (2.03–7.89)). Conclusion: Our findings show elevated use of mental health services by people with intellectual disability in the perinatal period and underscore the need for accessible and adequately equipped acute and community-based mental health services.


  • Open Access

    Manymak Djäma: A Yolŋu-Led Framework for Health Research “Work the Right Way” with Indigenous Australian Youth in Remote East Arnhem Land, Northern Territory, Australia

    by Natalia Gonzalez Bohorquez, Tamaa Lapurrangu Wurramarrba, Tina Mayulwuy Dhamarrandji, Anneke de Vries-Egan, Neeraj Gill, Lorelle Holland, Benson Rajan, Armita Adily, Steve Kisely, Alison Mitchell, et al.

    Background: The Yolŋu people of remote East Arnhem Land, northern Australia, maintain deep connections to gurruṯu (kinship), land, language, cultural practice, and Yolŋu lore. This cultural strength co-exists with health inequities shaped by colonisation, underscoring the need for Yolŋu-grounded approaches. This study aimed to articulate Yolŋu-defined guiding principles for Balanda (non-Yolŋu) researchers to enact manymak djäma (“work the right way”). Methods: Embedded in an Aboriginal Participatory Action Research project developing culturally grounded mental health care with Yolŋu youth, we adopted a qualitative, decolonising approach guided by nhina, nhäma ga ŋäma (sit, observe, and listen). Ethnography included field diaries and discussions with Yolŋu researchers, Elders, and community members. Yolŋu researchers articulated the principles through iterative discussions, informing Indigenist framework analysis. Findings: Fourteen interrelated principles were articulated. Gurruṯu governed relational positioning, obligations, engagement, knowledge access, and ethical practice. Manymak djäma required reciprocity, paid Yolŋu roles, collective participation, and attunement to Yolŋu governance and cultural rhythms. Knowledge exchange relied on community authority, Yolŋu first languages, deep listening, silence, storytelling, embodied communication, place-based metaphors, and truth-telling. Researchers lacked automatic entitlement to knowledge and followed Yolŋu protocols before invitation into deeper knowledge spaces. Interpretation: Manymak djäma is a community-authorised, gurruṯu-centred approach requiring institutions to relinquish control, respect Yolŋu governance, and engage in reciprocal learning and relational responsibility. This framework guides culturally grounded research, policy, and practice supporting collective healing among Indigenous youth in remote Australia. Consent was enacted as an ongoing, relational process, recognising linguistic, cultural, and contextual differences in how formal written information is understood. Information was shared verbally, iteratively, and in context, with consent supported by Yolŋu researchers, preferred language use, and, where appropriate, family and community discussions. Willingness to engage was revisited throughout, and withdrawal permitted at any time; parental or guardian consent was obtained for those under 18 years.

  • Open Access

    Use of Health Services by People With Dementia Who Self‐Harm in New South Wales, Australia: A Data Linkage Study

    by Adrian R. Walker, Preeyaporn Srasuebkul, Julian N. Trollor, Anne P. F. Wand, Brian Draper, Rachael C. Cvejic, Annette Moxey, Simone Reppermund

    Introduction: This study aimed to examine the patterns and predictors of health service use for people with dementia who self‐harmed. Methods: Using a retrospective linked cohort of people who accessed health services in New South Wales, Australia between 2001 and 2015, we identified 154,811 people with dementia or mild cognitive disorder (the dementia cohort), 28,972 people who self‐harmed (the self‐harm cohort), and 1541 who had a record of both dementia or mild cognitive disorder and self‐harm (the dementia and self‐harm subgroup). We examined the rates of health service use (inpatient hospital admissions, emergency department presentations, and mental health ambulatory days) for these cohorts. Using random effects Poisson regression and survival modelling, we investigated the change in and predictors of health service use following self‐harm (for those with dementia) or dementia diagnosis (for those who had self‐harmed). Results: People with dementia who self‐harmed had the highest rate of use of all health services. Ambulatory mental health service use increased after self‐harm for people in the dementia cohort, while emergency department and mental health related hospital presentations decreased. Hospitalisations for non‐mental health reasons increased after dementia diagnosis for those in the self‐harm cohort, but use of other services decreased. Ambulatory mental health service use predicted increased time to re‐presentation to hospital. Discussion: Health service use changed after an episode of self‐harm for people with dementia. People with dementia with poor mental health or substance use concerns may benefit from more proactive provision of mental health services.

  • Open Access

    Organised cancer screening among women who receive medically assisted reproduction treatments

    by Adrian Raymond Walker, Signe Opdahl, Christos Venetis, Louisa Jorm, Neville F Hacker, Michael Chapman, Antoinette C Anazodo, Robert J Norman, Catharyn Stern, Ursula M Sansom-Daly, et al.

    There are no published data on cancer screening by women using medically assisted reproduction (MAR). Such data would aid interpretation of the cancer incidence and risk profiles for this group. Using linked population-based Australian health registries and administrative datasets, we compared organised publicly funded cervical and breast screening episodes for women who received one of three types of MAR and matched women who did not between 1991 and 2016. We modelled the proportion of women screened in the three years before and after first MAR treatment, adjusting for age, remoteness, parity, socio-economic disadvantage, cancer history, and uptake of the other screening program. After adjustment, a greater proportion of women who received MAR than women who did not had cervical screening before MAR (77.3%-84.1% vs 57.5%-62.0%, depending on treatment) and after MAR (77.0%-78.5% vs 68.1%-68.3%). Contrastingly, breast screening estimates were 7.6%-9.6% vs 9.3%-10.5% before MAR and 11.0%-15.0% vs 12.8%-14.9% after MAR.

  • Open Access

    Medically Assisted Reproduction and Hormone-Related Cancers

    by Adrian Raymond Walker, Christos Venetis, Signe Opdahl, Antoinette C. Anazodo, Neville F. Hacker, Michael Chapman, Louisa Jorm, Robert J. Norman, Catharyn Stern, Ursula M. Sansom-Daly, et al.

    Importance: It is critical that women undertaking medically assisted reproductive (MAR) treatment and their clinicians know whether the treatments are associated with an increased risk of hormone-related cancers. Objective: To determine the risk of hormone-related cancers following MAR treatment. Design, Setting, and Participants: This cohort study used an emulated target trial design including Australian health registries and administrative datasets. Participants included women enrolled in Medicare, Australia’s universal health insurance scheme, aged 18 to 55 years between January 1, 1991, and December 31, 2018. Data were analyzed from April 2024 to July 2025. Exposures: Exposures were defined from Medicare records: assisted reproduction therapy, intrauterine insemination or ovarian stimulation, and ovulation induction with clomiphene citrate. Main Outcomes and Measures: Hormone-related invasive cancers (identified in the Australian Cancer Database) included breast, ovarian, uterine, thyroid, colorectal cancers and melanoma; in situ cancers included breast cancer and melanoma. Three cancers with no hormonal links—pancreatic, lung, and hematological—were included as negative controls. Flexible parametric survival models ascertained hazard ratios (HRs) and cumulative marginal survival differences in incident cancers per 100 000 population. E-values assessed the risk of bias due to unmeasured confounding. Results: A total of 1 748 927 women were identified, including 396 661 with history of MAR exposure. Although elevated risk of most hormone-related cancers was observed after MAR treatment (HRs, 1.09-1.64), E-value analysis suggested confounding due to underlying infertility conditions (ie, endometriosis, polycystic ovarian syndrome) could account for this observed elevation for uterine, ovarian, and thyroid cancers. For any specific invasive cancer, fewer than 20 extra cancers per 100 000 women each year were estimated for treated vs comparator groups. Emulated trials on the 6 hormone-related cancers and pancreatic and hematological cancers showed increased cancer risk in the first years after treatment, suggesting detection bias. Increased risk of hematological cancers was observed after MAR treatment (HRs, 1.18-1.27), indicating uncontrolled confounding by race and ethnicity may account for observed excess risk seen for several cancers. Some treatments were associated with decreased lung cancer risk (HRs, 0.72-0.82). Conclusions and Relevance: In this cohort study of MAR and cancer using a target trial emulation design, although associations between MAR and some hormone-related cancers were observed, the estimated difference in the number of expected cancers was small and may be explained by unmeasured confounding and detection bias.

  • Open Access

    Childhood cancer in singletons conceived via medically assisted reproduction in Australia: a population-based cohort study

    by Adrian Raymond Walker, Claire Melissa Vajdic, Antoinette C Anazodo, Neville F Hacker, Signe Opdahl, Michael Chapman, Ursula M Sansom-Daly, Louisa Jorm, Robert J Norman, Catharyn Stern, et al.

    Study question: Do singletons conceived by medically assisted reproduction (MAR) experience an elevated incidence of childhood cancers and are they at a greater risk of such cancers compared to naturally-conceived singletons? Summary answer: We found no strong evidence the adjusted risk of childhood cancers is increased for MAR-conceived singletons. What is known already: There is longstanding concern children conceived via MAR may be at increased risk of childhood cancer. Current epidemiological evidence does not support such a relationship. Study design, size, duration: We conducted a retrospective population-based cohort study of 5,104,121 singletons born in Australia between 1991 and 2019. Median follow-up time varied from 4 to 10 years depending on mode of conception. Participants/materials, setting, methods: We linked birth records to public medical insurance data of the mother to ascertain MAR conception. We classified treatment as ovulation induction/intrauterine insemination (OI/IUI) or assisted reproductive technology (ART; IVF/ICSI), with ART coded as either fresh embryo transfer or frozen embryo transfer. The cohort included 4,924,354 naturally-conceived singletons and 179,767 singletons conceived via MAR. We calculated standardised incidence ratios (SIRs) to ascertain differences in population incidence of childhood cancer, and generated hazard ratios (HRs) using flexible parametric survival models controlling for key confounders. We report absolute incidence and risk differences for both statistical approaches. Main results and the role of chance: There was no increase in the incidence or risk of all childhood cancers combined for singletons conceived via MAR, either any MAR or specific MAR types. There was some evidence the incidence of leukemias, myeloproliferative diseases, and myelodysplastic diseases was increased after ART compared to the general population (SIR: 1.32, 95% CI 1.02-1.68; equating to 2.09, 95% CI 0.13-4.44 extra cancers per 100,000 person-years), but no increased risk after adjusting for available confounders (HR: 1.04, 95% CI 0.73-1.46). These cancers showed increased incidence and risk for those conceived via IVF (SIR: 1.54, 95% CI 1.01-2.26; HR: 1.77, 95% CI 1.06-2.95), but not ICSI (SIR: 1.27, 95% CI 0.83-1.85; HR: 0.76, 95% CI 0.48-1.22). Incidence of renal tumours was elevated after IVF (SIR: 2.37, 95% CI 1.02-4.67; equating to 1.83, 95% CI 0.03-3.99 extra cancers per 100,000 person-years) and frozen transfer ART (SIR: 2.52, 95% CI 1.09-4.97; equating to 2.12, 95%CI 0.12-5.53 extra cancers per 100,000 person-years), however risk was not elevated after adjusting for available confounders (HR: 1.06, 95% CI 0.47-2.38; and HR: 1.63, 95% CI 0.73-3.61 respectively). Limitations, reasons for caution: We did not have information on parental cause of infertility, which could be a confounder for childhood cancer, although we did adjust for parental history of cancer. For many specific cancer types, fewer than 50 cases were observed in total. Given the number of comparisons reported and closeness of the lower-bound confidence interval to 1, we cannot exclude that a significant association between conception via IVF and leukemias, myeloproliferative diseases, and myelodysplastic diseases reflects a type I error. Wider implications of the findings: Our findings align generally with published meta-analyses on the risk of childhood cancers following MAR conception and reinforce the need for very large studies to increase confidence. Parents who have conceived via MAR and their offspring can be reassured there is not strong evidence the treatments increase the overall incidence or risk of childhood cancer.

  • Open Access

    Assessing the effect of medically assisted reproduction on hormone-related cancers in women: an emulated target trial

    by Adrian Raymond Walker, Christos Venetis, Signe Opdahl, Antoinette C Anazodo, Neville Hacker, Michael Champman, Louisa Jorm, Robert J Norman, Catharyn Stern, Ursula M Sansom-Daly, et al.

    1. Objective: To determine the risk of hormone-related cancers following medically assisted reproductive treatment. Design: Emulated target trial. Setting: Australian health registries and administrative datasets. Participants: 1,748,927 women enrolled in Medicare, Australia’s universal health insurance scheme, aged 18 to 55 between 1 January 1991 and 31 December 2018. Interventions: Three exposures were defined from Medicare records of reimbursement for consultations, procedures and medications: assisted reproduction therapy (ART); intrauterine insemination/ovarian stimulation (IUI/OS); and ovulation induction with Clomiphene Citrate. Main outcome measures: Hormone-related invasive cancers included breast, ovarian, uterine, thyroid, colorectal, and melanoma; in-situ cancers included breast and melanoma. Three cancers with no established hormonal links and high incidence – pancreatic, lung, and haematological – were included as negative controls. Flexible parametric survival models ascertained hazard ratios and cumulative marginal differences in incident cancers per 100,000 women. E-values assessed the risk of bias due to unmeasured confounding variables. Results: Though most hormone-related cancers were elevated after MAR treatment (HRs: 1.09-1.64), E-value analysis suggested confounding due to underlying infertility conditions (endometriosis, polycystic ovarian syndrome) could account for this observed elevation for uterine, ovarian, and thyroid cancers. For any specific invasive cancer, fewer than 20 extra cancers per 100,000 women each year were predicted for treated versus comparator women. Emulated trials on the six hormone-related cancers showed increased cancer risk in the first years after treatment, however this was also observed for pancreatic and haematological cancers, suggesting detection bias. Haematological cancers showed an increased risk after treatment (HRs: 1.19-1.27), indicating uncontrolled confounding by ethnicity may account for the excess risk observed for haematological cancers and melanoma. Lung cancer risk was decreased after some treatments (HRs: 0.73-0.83). Conclusions: Though MAR showed an association with some hormone-related cancers, the absolute difference in the number of expected cancers was small and may be explained by unmeasured confounding and detection bias. 2. SUMMARY BOXES: Section 1: What is already known on this topic: There is a biologically plausible link between medically assisted reproduction therapies and hormone-related cancers. Current evidence suggests exposure to medically assisted reproduction does not increase the risk of most hormone-related cancers. Assessments of causation in this context are challenging, as women undertaking medically assisted reproduction have a different hormone-related cancer risk profile to those who do not. Section 2: What this study adds: This study is one of the largest examinations of women’s cancer risk following medically assisted reproduction and the first to use both the emulated target trial framework and negative control cancers, and to quantify the potential for unmeasured confounding. Most hormone-related cancers show a small elevation in relative and absolute risk following medically assisted reproduction therapies, though this may be due in part or whole to detection bias and unmeasured confounding from infertility-related conditions like endometriosis or polycystic ovary syndrome, anovulation, obesity, and ethnicity. This study provides a comprehensive assessment of the available evidence and guidance for improving future research on medically assisted reproduction and cancer.

  • Open Access

    Mortality in people living with dementia who self-harmed: An Australian data linkage study

    by Adrian R Walker, Preeyaporn Srasuebkul, Julian N Trollor, Anne Pf Wand, Brian Draper, Rachael C Cvejic, Annette Moxey, Simone Reppermund

    Objectives: This study aimed to examine mortality for people living with dementia/mild cognitive impairment who self-harmed. Methods: We conducted a retrospective cohort study in New South Wales, Australia, using data ranging from 2001 to 2015. From people who accessed hospital services in the study period, we identified 154,811 people living with dementia/mild cognitive impairment, 28,972 who self-harmed and 1511 who had a record of both dementia/mild cognitive impairment and self-harm. We examined rates, causes and predictors of death for people with dementia/mild cognitive impairment and/or self-harm diagnoses using flexible parametric survival analyses. We explored rates of repeat self-harm in people living with dementia who self-harmed. Results: Circulatory disorders accounted for 32.0% of deaths in people with a living with dementia who self-harmed, followed by neoplasms (14.7%), and mental and behavioural disorders (9.6%). Death was more likely for someone who had self-harmed if they developed dementia/mild cognitive impairment. Predictors of death included male sex, greater physical comorbidity, a history of delirium, more previous emergency department presentations and fewer previous mental health ambulatory service days. Greater engagement with outpatient mental health services predicted a decreased likelihood of repeat self-harm. Discussion: We found that mortality increases when people who self-harm develop dementia. We argue post-diagnosis support offers a potential opportunity to reduce mortality rates in people with both dementia and self-harm diagnoses.


  • Open Access

    Estimating the impact of bias in causal epidemiological studies: the case of health outcomes following assisted reproduction

    by Adrian R Walker, Christos A Venetis, Signe Opdahl, Georgina M Chambers, Louisa R Jorm, Claire M Vajdic

    Researchers interested in causal questions must deal with two sources of error: random error (random deviation from the true mean value of a distribution), and bias (systematic deviance from the true mean value due to extraneous factors). For some causal questions, randomization is not feasible, and observational studies are necessary. Bias poses a substantial threat to the validity of observational research and can have important consequences for health policy developed from the findings. The current piece describes bias and its sources, outlines proposed methods to estimate its impacts in an observational study, and demonstrates how these methods may be used to inform debate on the causal relationship between medically assisted reproduction (MAR) and health outcomes, using cancer as an example. In doing so, we aim to enlighten researchers who work with observational data, especially regarding the health effects of MAR and infertility, on the pitfalls of bias, and how to address them. We hope that, in combination with the provided example, we can convince readers that estimating the impact of bias in causal epidemiologic research is not only important but necessary to inform the development of robust health policy and clinical practice recommendations.


  • Open Access

    Risk factors for dementia and self‐harm: A linkage study

    by Adrian R. Walker, Preeyaporn Srasuebkul, Julian N. Trollor, Anne P. F. Wand, Brian Draper, Rachael C. Cvejic, Annette Moxey, Simone Reppermund

    Introduction: People living with dementia experience poor mental health and high rates of self‐harm. We investigated risk factors for self‐harm in people aged > 40 years living with dementia and risk factors for dementia after self‐harm.Methods: Using linked hospital data from New South Wales, Australia, we defined a dementia cohort (n = 154,811) and a self‐harm cohort (n = 28,972). Using survival analyses, we investigated predictors of self‐harm for the dementia cohort, and predictors of dementia for the self‐harm cohort.Results: We found self‐harm or dementia diagnoses occurred most often within 24 months of a dementia diagnosis or initial self‐harm presentation, respectively. Men living with dementia, and people with complex psychiatric profiles, had the greatest risk of self‐harm. Men who had self‐harmed had the greatest risk of dementia diagnoses.Discussion: Men and people with complex psychiatric profiles and dementia may particularly benefit from post‐diagnosis mental and behavioral support to reduce risk of self‐harm.